Zhang Wei, J. Koya, Xingduo Dong, S. Reznik, Z. Chen
{"title":"Entospletinib。脾酪氨酸激酶(SYK)抑制剂,血液肿瘤治疗","authors":"Zhang Wei, J. Koya, Xingduo Dong, S. Reznik, Z. Chen","doi":"10.1358/dof.2022.47.2.3360406","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Entospletinib. Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy\",\"authors\":\"Zhang Wei, J. Koya, Xingduo Dong, S. Reznik, Z. Chen\",\"doi\":\"10.1358/dof.2022.47.2.3360406\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11366,\"journal\":{\"name\":\"Drugs of The Future\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs of The Future\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1358/dof.2022.47.2.3360406\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs of The Future","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1358/dof.2022.47.2.3360406","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
期刊介绍:
A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions.
The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.